Deal dynamics between Chinese biotechs and global pharma companies are changing fast, with the biotechs seeking higher ...

Improved survival on display at the American Society of Clinical Oncology (ASCO) in Chicago; Pfizer’s unusual pact with China ...

Drug production is expected to be one of the main drivers of employment growth in U.S. manufacturing through 2034, with the ...

Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data ...

When used alongside Merck’s Keytruda, Moderna’s personalized cancer vaccine halved the risk of death or disease recurrence in ...

Government backing, deep scientific talent and a robust pharma heritage are helping France punch above its weight, but ...

For Peter Pitts, a former associate commissioner at the FDA, the appointment to the board of BrainStorm Cell Therapeutics is ...

The American Diabetes Association's annual congress will feature a superstar lineup, including weight loss giants Eli Lilly ...

Analysts, investors and partner Summit Therapeutics had all been keenly awaiting the overall survival update, after previous ...

After trial flops in spinal muscular atrophy, depression and bipolar disorder—and a costly rare disease drug ...

PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing ...

Under the temporary reign of top food executive Kyle Diamantas, the FDA will sustain programs initiated by former ...